TR200102178T2 - CRF reseptör antagonistleri ve bunlarla ilgili yöntemler. - Google Patents
CRF reseptör antagonistleri ve bunlarla ilgili yöntemler.Info
- Publication number
- TR200102178T2 TR200102178T2 TR2001/02178T TR200102178T TR200102178T2 TR 200102178 T2 TR200102178 T2 TR 200102178T2 TR 2001/02178 T TR2001/02178 T TR 2001/02178T TR 200102178 T TR200102178 T TR 200102178T TR 200102178 T2 TR200102178 T2 TR 200102178T2
- Authority
- TR
- Turkey
- Prior art keywords
- receptor antagonists
- related methods
- crf receptor
- compounds
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/16—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Sicak kanli bir hayvanda felç gibi asiri CRF salgilanmasina neden olan rahatsizliklarin tedavisi dahil, çesitli rahatsizliklarin tedavisinde kullanilan CRF reseptörü antagonistleri tarif edilmektedir. Bu bulusun bilesikleri (I) yapisina sahiptir ve bunlarin stereoizomerleri ve farmasötik olarak uygun tuzlari dahildir, burada n, m, R, R1, R2, X ve Ar burada tanimlandigi gibidir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19095898A | 1998-11-12 | 1998-11-12 | |
US40074499A | 1999-09-21 | 1999-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102178T2 true TR200102178T2 (tr) | 2002-01-21 |
Family
ID=26886600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02178T TR200102178T2 (tr) | 1998-11-12 | 1999-11-12 | CRF reseptör antagonistleri ve bunlarla ilgili yöntemler. |
Country Status (19)
Country | Link |
---|---|
US (3) | US6348466B1 (tr) |
EP (1) | EP1129096B1 (tr) |
JP (1) | JP2002529469A (tr) |
KR (1) | KR20010080402A (tr) |
CN (1) | CN1178941C (tr) |
AT (1) | ATE240958T1 (tr) |
AU (1) | AU755997B2 (tr) |
BR (1) | BR9915129A (tr) |
CA (1) | CA2349904A1 (tr) |
DE (1) | DE69908173T2 (tr) |
DK (1) | DK1129096T3 (tr) |
ES (1) | ES2196898T3 (tr) |
HK (1) | HK1038925B (tr) |
IL (1) | IL143105A0 (tr) |
NO (1) | NO20012228L (tr) |
NZ (1) | NZ511267A (tr) |
PT (1) | PT1129096E (tr) |
TR (1) | TR200102178T2 (tr) |
WO (1) | WO2000027850A2 (tr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2398956A1 (en) * | 2000-02-14 | 2001-08-16 | Japan Tobacco Inc. | A pharmaceutical composition for prophylaxis or therapy of a postoperative stress |
EP1278751A1 (en) * | 2000-05-01 | 2003-01-29 | Bristol-Myers Squibb Pharma Company | Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists |
EP1282624B1 (en) | 2000-05-18 | 2004-03-03 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
EP1282622B1 (en) | 2000-05-18 | 2003-09-17 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
CA2427656A1 (en) | 2000-11-03 | 2002-05-23 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
KR100843281B1 (ko) | 2000-12-28 | 2008-07-09 | 오노 야꾸힝 고교 가부시키가이샤 | 삼환식 복소환 유도체 화합물 및 그 화합물을 유효성분으로 하는 의약 |
EP1345938A1 (en) | 2000-12-28 | 2003-09-24 | Neurocrine Biosciences, Inc. | Tricyclic crf receptor antagonists |
JP2004528342A (ja) * | 2001-04-30 | 2004-09-16 | グラクソ グループ リミテッド | Crf受容体アンタゴニスト |
US7273871B2 (en) | 2001-07-17 | 2007-09-25 | Sb Pharmco Puerto Rico Inc. | Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists |
GB0117395D0 (en) * | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
NZ544301A (en) | 2003-06-25 | 2008-08-29 | Ono Pharmaceutical Co | Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
US20060024661A1 (en) * | 2003-07-30 | 2006-02-02 | The Regents Of The University Of California | Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2 |
US20070293508A1 (en) * | 2003-12-22 | 2007-12-20 | Sb Pharmco Puerto Rico Inc And Neurocrine Biosciences, Inc. | Crf Receptor Antagonists and Methods Relating Thereto |
AU2005250056A1 (en) | 2004-06-03 | 2005-12-15 | Athlomics Pty Ltd | Agents and methods for diagnosing stress |
WO2006031322A2 (en) * | 2004-08-09 | 2006-03-23 | Research Development Foundation | Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis |
WO2007050087A1 (en) | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
IN2014CN03762A (tr) | 2004-08-25 | 2015-09-25 | Ardea Biosciences Inc | |
CA2607021C (en) | 2005-05-05 | 2013-10-29 | Ardea Biosciences, Inc. | Diaryl-purines, -azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
EP2132211A4 (en) | 2006-11-09 | 2011-12-07 | Ardea Biosciences Inc | 4-CYANPHENYLAMINO-SUBSTITUTED BICYCLIC AND HETEROCYCLIC COMPOUNDS AS AN HIV HEMMER |
EA018193B3 (ru) | 2007-11-27 | 2014-07-30 | Ардеа Биосайнсиз Инк. | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты |
US8207178B2 (en) | 2007-12-14 | 2012-06-26 | Ardea Biosciences, Inc. | Fused pyrimidines as reverse transcriptase inhibitors |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4605642A (en) | 1984-02-23 | 1986-08-12 | The Salk Institute For Biological Studies | CRF antagonists |
US5013737A (en) * | 1988-02-22 | 1991-05-07 | American Cyanamid Company | 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones |
US4904658A (en) | 1988-04-15 | 1990-02-27 | American Cyanamid Company | Substituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and substituted-6H,10H-pyrimido[1,2-cd]purin-10-ones |
US5063245A (en) | 1990-03-28 | 1991-11-05 | Nova Pharmaceutical Corporation | Corticotropin-releasing factor antagonism compounds |
FR2692893B1 (fr) | 1992-06-24 | 1994-09-02 | Sanofi Elf | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
DK0674631T3 (da) | 1992-12-17 | 2000-04-10 | Pfizer | Substituerede pyrazoler som CRF-antogonister |
TW336932B (en) | 1992-12-17 | 1998-07-21 | Pfizer | Amino-substituted pyrazoles |
KR0170567B1 (ko) | 1992-12-17 | 1999-02-18 | 알렌 제이. 스피겔 | 부신피질자극호르몬-유리 인자 길항물질 활성을 갖는 피라졸 및 피라졸로피리미딘 |
TW370529B (en) * | 1992-12-17 | 1999-09-21 | Pfizer | Pyrazolopyrimidines |
US6765008B1 (en) * | 1992-12-17 | 2004-07-20 | Pfizer Inc | Pyrrolopyrimidines as CRF antagonists |
JP3398152B2 (ja) | 1993-10-12 | 2003-04-21 | ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー | 1n−アルキル−n−アリールピリミジンアミンおよびその誘導体 |
TW530047B (en) | 1994-06-08 | 2003-05-01 | Pfizer | Corticotropin releasing factor antagonists |
JP2891544B2 (ja) | 1994-06-16 | 1999-05-17 | ファイザー・インコーポレーテッド | ピラゾロおよびピロロピリジン類 |
AU716993B2 (en) | 1995-05-12 | 2000-03-16 | Neurogen Corporation | Novel deazapurine derivatives; a new class of CRF1 specific ligands |
FR2735777B1 (fr) | 1995-06-21 | 1997-09-12 | Sanofi Sa | Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
JP2000507552A (ja) | 1996-03-26 | 2000-06-20 | デュポン ファーマシューティカルズ カンパニー | アリールオキシおよびアリールチオ縮合ピリジン、アリールオキシおよびアリールチオ縮合ピリミジン、およびそれらの誘導体 |
US6326368B1 (en) | 1996-03-27 | 2001-12-04 | Dupont Pharmaceuticals Company | Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof |
US6107300A (en) | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
ZA973884B (en) | 1996-05-23 | 1998-11-06 | Du Pont Merck Pharma | Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
EP0915880B1 (en) | 1996-07-24 | 2007-10-10 | Bristol-Myers Squibb Pharma Company | Azolo triazines and pyrimidines |
ATE232863T1 (de) | 1996-08-06 | 2003-03-15 | Pfizer | Substituierte pyrido- oder pyrimidogruppen enthaltende 6,6- oder 6,7-bicyclische derivate |
TW477787B (en) | 1996-08-27 | 2002-03-01 | Pfizer | Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same |
AU735401B2 (en) * | 1996-08-28 | 2001-07-05 | Pfizer Inc. | Substituted 6,5-hetero-bicyclic derivatives |
EP0927171B1 (en) | 1996-09-16 | 2002-02-20 | Du Pont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
FR2754258B1 (fr) | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
US5760225A (en) | 1996-11-15 | 1998-06-02 | Neurogen Corporation | Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands |
US5723608A (en) | 1996-12-31 | 1998-03-03 | Neurogen Corporation | 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands |
-
1999
- 1999-11-12 ES ES99961675T patent/ES2196898T3/es not_active Expired - Lifetime
- 1999-11-12 US US09/439,841 patent/US6348466B1/en not_active Expired - Fee Related
- 1999-11-12 PT PT99961675T patent/PT1129096E/pt unknown
- 1999-11-12 TR TR2001/02178T patent/TR200102178T2/tr unknown
- 1999-11-12 IL IL14310599A patent/IL143105A0/xx unknown
- 1999-11-12 CN CNB998131725A patent/CN1178941C/zh not_active Expired - Fee Related
- 1999-11-12 WO PCT/US1999/026984 patent/WO2000027850A2/en not_active Application Discontinuation
- 1999-11-12 DE DE69908173T patent/DE69908173T2/de not_active Expired - Lifetime
- 1999-11-12 AU AU18199/00A patent/AU755997B2/en not_active Ceased
- 1999-11-12 NZ NZ511267A patent/NZ511267A/xx unknown
- 1999-11-12 CA CA002349904A patent/CA2349904A1/en not_active Abandoned
- 1999-11-12 BR BR9915129-4A patent/BR9915129A/pt not_active IP Right Cessation
- 1999-11-12 EP EP99961675A patent/EP1129096B1/en not_active Expired - Lifetime
- 1999-11-12 DK DK99961675T patent/DK1129096T3/da active
- 1999-11-12 KR KR1020017005818A patent/KR20010080402A/ko not_active Application Discontinuation
- 1999-11-12 JP JP2000581028A patent/JP2002529469A/ja active Pending
- 1999-11-12 AT AT99961675T patent/ATE240958T1/de not_active IP Right Cessation
-
2001
- 2001-05-04 NO NO20012228A patent/NO20012228L/no not_active Application Discontinuation
- 2001-12-20 US US10/027,789 patent/US6723721B2/en not_active Expired - Lifetime
-
2002
- 2002-01-29 HK HK02100689.4A patent/HK1038925B/zh not_active IP Right Cessation
-
2004
- 2004-02-23 US US10/785,386 patent/US20040229879A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002529469A (ja) | 2002-09-10 |
BR9915129A (pt) | 2001-08-07 |
DE69908173D1 (de) | 2003-06-26 |
WO2000027850A3 (en) | 2000-08-03 |
HK1038925A1 (en) | 2002-04-04 |
CN1178941C (zh) | 2004-12-08 |
DE69908173T2 (de) | 2004-08-19 |
IL143105A0 (en) | 2002-04-21 |
US6348466B1 (en) | 2002-02-19 |
US20020143008A1 (en) | 2002-10-03 |
ATE240958T1 (de) | 2003-06-15 |
NO20012228D0 (no) | 2001-05-04 |
AU755997B2 (en) | 2003-01-02 |
CN1326458A (zh) | 2001-12-12 |
DK1129096T3 (da) | 2003-09-15 |
NO20012228L (no) | 2001-05-04 |
EP1129096A2 (en) | 2001-09-05 |
ES2196898T3 (es) | 2003-12-16 |
PT1129096E (pt) | 2003-09-30 |
HK1038925B (zh) | 2003-12-05 |
WO2000027850A2 (en) | 2000-05-18 |
AU1819900A (en) | 2000-05-29 |
EP1129096B1 (en) | 2003-05-21 |
NZ511267A (en) | 2002-12-20 |
US6723721B2 (en) | 2004-04-20 |
KR20010080402A (ko) | 2001-08-22 |
CA2349904A1 (en) | 2000-05-18 |
US20040229879A1 (en) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102178T2 (tr) | CRF reseptör antagonistleri ve bunlarla ilgili yöntemler. | |
NO20012194D0 (no) | CRF-reseptorantagonister og tilhörende fremgangsmåter | |
WO2001066534A3 (en) | Cyclic and bicyclic diamino histamine-3 receptor antagonists | |
SE9900100D0 (sv) | New compounds | |
MA26846A1 (fr) | Derives de 2,4-diaminopyrimidine utiles comme agents immunosuppresseurs. | |
IT1304499B1 (it) | Procedimento per ridurre il peso molecolare di copolimeri eterpolimeri dell'etilene. | |
NO20035148D0 (no) | Tri- og tetra-aza-acenaftylenderivater som CRF- reseptorantagonister | |
MXPA03003714A (es) | Antagonistas del receptor crf y metodos relacionados con los mismos. | |
MXPA04006571A (es) | Derivado de pirimidina biciclica fusionada. | |
TR200101654T2 (tr) | Vitronektin reseptr antagonistleri | |
EA200400822A1 (ru) | Производные 3,4-дигидро-1h-изохинолин-2-ила | |
DE60100811D1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
DE60102231D1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
SE0103795D0 (sv) | Compounds and method for the treatment of överactive bladder | |
EP1020467A4 (en) | N-ACYLAMINO ACID AMIDE COMPOUNDS AND INTERMEDIATES USEFUL IN THE PREPARATION THEREOF | |
DE602004012318D1 (de) | Crf-rezeptorantagonisten und diese betreffende verfahren | |
ITUD20020265A1 (it) | Procedimento per la realizzazione di un pilastro e di un nodo a struttura mista, e pilastro cosi' ottenuto | |
IT1311584B1 (it) | Metodo per la realizzazione di calzature, e calzature ottenute contale metodo. |